Capecitabine + pembrolizumab for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Feb 2016: Trial started, NCT02734290
  2. 12 Apr 2016: Trial registered, NCT02734290

The trials

NCT02734290: Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

State
Under way
Phase
Phase 1 and Phase 2
People
29 taking part
Started
23 Feb 2016
Primary completion
21 Aug 2019
Arms
Arm B
Results
Posted on the registry
  1. 23 Feb 2016: Trial started
  2. 12 Apr 2016: Trial registered
  3. 22 Feb 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.